ACRVHealthcareMicro-Cap
Acrivon Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Acrivon Therapeutics, Inc. (ACRV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ACRV insiders buying or selling?
Acrivon Therapeutics, Inc. insiders reported 6 open-market buys ($67.5M) and 5 sells ($3.9M) across 11 Form 4 filings — a net buying position of $63.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jan 16, 2026)
Total Form 4 filings
11
SEC EDGAR
Insider filers
6
Insider buys (6)
$67.5M
Insider sells (5)
$3.9M
Insider sentiment
Net buyingNet insider flow of $63.6M in net buying.
Recent ACRV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 16, 2026 | Peter Blume-Jensen | President and CEO | Purchase | 49.0K | $1.68 | $82.1K |
| Jan 16, 2026 | Adam D. Levy | Chief Financial Officer | Purchase | 8.8K | $1.70 | $15.0K |
| Jan 15, 2026 | Eric Devroe | Chief Operating Officer | Purchase | 10.0K | $1.72 | $17.2K |
| May 1, 2025 | Joseph Edelman | 10% Owner | Sale | 736.8K | $1.38 | $1.0M |
| Apr 29, 2025 | Joseph Edelman | 10% Owner | Sale | 1.5M | $1.81 | $2.7M |
| Apr 15, 2024 | Joseph Edelman | 10% Owner | Purchase | 2.4M | $8.50 | $20.0M |
| Jun 28, 2023 | Marcin Czernik | 10% Owner | Sale | 16 | $12.93 | $206.88 |
| Jun 20, 2023 | Marcin Czernik | 10% Owner | Sale | 2.1K | $12.14 | $25.0K |
| Jun 14, 2023 | Marcin Czernik | 10% Owner | Sale | 5.9K | $12.29 | $72.4K |
| Nov 21, 2022 | Marcin Czernik | 10% Owner | Purchase | 400.0K | $12.50 | $5.0M |
| Nov 21, 2022 | Peter Kolchinsky | Director, 10% Owner | Purchase | 3.4M | $12.50 | $42.4M |
Showing the 11 most recent of 11 Form 4 filings for Acrivon Therapeutics, Inc..
Most active ACRV insiders
- Marcin Czernik4 filings
- Joseph Edelman3 filings
- Adam D. Levy1 filing
- Eric Devroe1 filing
- Peter Blume-Jensen1 filing
Ask anything about ACRV insider activity
Use Trabud's AI agent to query Acrivon Therapeutics, Inc.'s Form 4 history in plain English — "Show me ACRV CEO purchases this year" or compare it against any other ticker.
Open the AI agentACRV insider trading FAQ
Are Acrivon Therapeutics, Inc. insiders buying or selling?
Across 11 SEC Form 4 filings, Acrivon Therapeutics, Inc. (ACRV) insiders reported 6 open-market purchases totaling $67.5M and 5 sales totaling $3.9M. That is a net buying position of $63.6M.
How many insiders trade ACRV stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Acrivon Therapeutics, Inc.. The most recent filing was accepted on Jan 16, 2026.
Where does Trabud get ACRV insider trading data?
All ACRV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.